Summary of Original Version

Amend KRS 304.17A-164 to prohibit insurers, pharmacy benefit managers, and other pharmacy benefit administrators from requiring or incentivizing the use of a mail-order pharmaceutical distributor; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply provisions of amended KRS 304.17A-164 to limited health service benefit plans, including limited health service contracts, limited health service organizations, the state employee health plan, and postsecondary educational institution self-insured group health plans; repeal 304.38A-120, relating to assignment of certain benefits under limited health service organization plans, to consolidate like provisions; make technical corrections; EFFECTIVE January 1, 2025.

Summary of Amendment: House Committee Substitute 1

Summary Retain original provisions, except amend definition of "insurer" to make technical amendment; add definition of "mail-order pharmaceutical distributor"; delete prohibition on requiring or incentivizing use of a mail-order pharmaceutical distributor; prohibit imposing greater or more restrictive requirements for use of a retail pharmacy to access a drug in certain circumstances.

Summary of Amendment: Senate Committee Substitute 1

Summary Delete original provisions; amend 2024 Ky. Acts. ch. 104, sec. 3 (2024 RS SB 188/GA, sec. 3) to define "national average drug acquisition cost"; temporarily exempt retail chain pharmacies from minimum drug reimbursement requirement; make technical amendment; EFFECTIVE January 1, 2025.